Oncology News

Pembrolizumab prolonged OS compared with placebo for certain patients with advanced hepatocellular carcinoma, according to topline data released by the agent’s manufacturer.

The FDA granted orphan drug designation to nadunolimab for the treatment of pancreatic cancer.

Fully automated magnetically controlled capsule endoscopy performed similarly to conventional transoral gastroscopy and may be an effective method for gastrointestinal tract examination, according to research.

Patients who underwent complete omentectomy for gastric cancer had decreased overall survival rates compared with patients who underwent non-complete omentectomy, according to research published in BMC Gastroenterology.

The American Gastroenterological Association published a conceptual model and clinical practice update for the prevention, detection and management of colorectal dysplasia in patients with inflammatory bowel disease.

Incidence of early-onset colorectal cancer has increased in the United States over the past 2 decades, but trends vary considerably by race and ethnicity, according to study results published in Clinical Gastroenterology and Hepatology.

A family history of Barrett’s esophagus or esophageal adenocarcinoma may serve as an early identifier of patients at a high risk for esophageal adenocarcinoma-related mortality.

According to projections in JAMA Oncology, it will take over 25 years to slow increasing oropharynx cancer incidence by human papillomavirus vaccinations because the disease will be observed in older population not yet vaccinated.

The International Hepato-Pancreato-Biliary Association established consensus guidelines for liver transplantation among patients with nonresectable colorectal liver metastases.

The FDA cleared an investigational new drug application for GCC19CART, a chimeric antigen receptor T-cell therapy designed to treat patients with relapsed or refractory metastatic colorectal cancer.